Related Experiment Video
Updated: Jul 12, 2025

Regulatory T cells: Therapeutic Potential for Treating Transplant Rejection and Type I Diabetes
Published on: August 20, 2007
Zebras Among Us: Advocating for the 30 Million Americans Living with Rare Disease
Eric L Wan1, Yehuda Elkaim2, William Gao2
1Georgetown University School of Medicine, 3900 Reservoir Rd NW, Washington, DC 20007 USA.
Abstract:
Nearly 30 million (about 1 in 10) Americans have a rare disease. On average, rare disease patients wait 6 years for an accurate and definitive diagnosis and see as many as 12 specialists along their diagnostic journey. In this brief article, we highlight some of what is being done across patient care, medical education, policy, and innovation in order to improve the diagnostic and treatment journeys of rare disease patients. We hope that members of the medical education community will appreciate this call to action and engage in the rare disease space.
Related Concept Videos
Healthcare Agencies I
Standards of Care II
Standards of Care I
Cystic Fibrosis: Management
Sinus disease and chronic...
Prescription, Nonprescription and Orphan Drugs
The misuse and addiction to prescription drugs is a growing problem that can affect people of all age groups, specifically teenagers. This can happen when prescription medications are used in ways not intended by the prescriber, such as taking someone else's prescription or using medication for...
Nursing Ethical Principles II
Consider the following scenario, which illustrates how these principles are applied in the care of Mr. John, a fifty-year-old teacher diagnosed with metastatic liver cancer.
Initially, Mr. John's...

